Correlation Between NeuPath Health and CHEVRON CDR

Can any of the company-specific risk be diversified away by investing in both NeuPath Health and CHEVRON CDR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuPath Health and CHEVRON CDR into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NeuPath Health and CHEVRON CDR, you can compare the effects of market volatilities on NeuPath Health and CHEVRON CDR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuPath Health with a short position of CHEVRON CDR. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuPath Health and CHEVRON CDR.

Diversification Opportunities for NeuPath Health and CHEVRON CDR

-0.67

Correlation Coefficient

NeuPath Health  CHEVRON CDR

Excellent diversification

The 3 months correlation between NeuPath and CHEVRON is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding NeuPath Health and CHEVRON CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CHEVRON CDR and NeuPath Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuPath Health are associated (or correlated) with CHEVRON CDR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CHEVRON CDR has no effect on the direction of NeuPath Health i.e., NeuPath Health and CHEVRON CDR go up and down completely randomly.

Pair Corralation between NeuPath Health and CHEVRON CDR

Assuming the 90 days trading horizon NeuPath Health is expected to under-perform the CHEVRON CDR. In addition to that, NeuPath Health is 2.97 times more volatile than CHEVRON CDR. It trades about -0.04 of its total potential returns per unit of risk. CHEVRON CDR is currently generating about 0.2 per unit of volatility. If you would invest  1,887  in CHEVRON CDR on September 4, 2024 and sell it today you would earn a total of  286.00  from holding CHEVRON CDR or generate 15.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

NeuPath Health  vs.  CHEVRON CDR

NeuPath Health

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NeuPath Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

CHEVRON CDR

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in CHEVRON CDR are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of rather abnormal technical and fundamental indicators, CHEVRON CDR exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NeuPath Health and CHEVRON CDR

The main advantage of trading using opposite NeuPath Health and CHEVRON CDR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuPath Health position performs unexpectedly, CHEVRON CDR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CHEVRON CDR will offset losses from the drop in CHEVRON CDR's long position.

The idea behind NeuPath Health and CHEVRON CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.